Get the Stockscreener App
17.85
0.28%
0.05
Oculis Holding Ag stock is traded at $17.85, with a volume of 17,831.
It is up +0.28% in the last 24 hours and up +1.25% over the past month.
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
See More
Previous Close:
$17.80
Open:
$17.88
24h Volume:
17,831
Relative Volume:
0.95
Market Cap:
$779.37M
Revenue:
-
Net Income/Loss:
$-75.28M
P/E Ratio:
-8.9442
EPS:
-1.9957
Net Cash Flow:
$-57.45M
1W Performance:
-0.28%
1M Performance:
+1.25%
6M Performance:
-16.63%
1Y Performance:
+50.06%
1-Day Range:
$17.68
$18.23
1-Week Range:
$17.51
$18.23
52-Week Range:
$11.56
$23.08
Oculis Holding Ag Stock (OCS) Company Profile
Compare OCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OCS
Oculis Holding Ag
|
17.85 | 921.67M | 0 | -75.28M | -57.45M | -1.9957 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Oculis Holding Ag Stock (OCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-05-23 | Initiated | Chardan Capital Markets | Buy |
| Oct-05-23 | Initiated | Stifel | Buy |
| Jun-14-23 | Initiated | BofA Securities | Buy |
| Jun-12-23 | Initiated | H.C. Wainwright | Buy |
| Jun-08-23 | Initiated | Robert W. Baird | Outperform |
| May-10-23 | Initiated | Pareto | Buy |
| Apr-28-23 | Initiated | Wedbush | Outperform |
View All
Oculis Holding Ag Stock (OCS) Latest News
Analyzing drawdowns of Oculis Holding AG Equity Warrant with statistical toolsWeekly Loss Report & Free Growth Oriented Trading Recommendations - Newser
Is this a good reentry point in Oculis Holding AG Equity WarrantShare Buyback & Verified Trade Idea Suggestions - Newser
What Fibonacci levels say about Oculis Holding AG reboundJuly 2025 Spike Watch & Capital Protection Trading Alerts - Newser
Oculis Holding AG Equity Warrant stock retracement – recovery analysisEarnings Beat & Intraday High Probability Alerts - Newser
Will Oculis Holding AG Equity Warrant continue its uptrendQuarterly Growth Report & AI Forecast for Swing Trade Picks - Newser
How moving averages guide Oculis Holding AG Equity Warrant trading2025 Risk Factors & Expert Approved Trade Ideas - Newser
Tick level data insight on Oculis Holding AG Equity Warrant volatilityJuly 2025 Price Swings & Capital Efficient Trade Techniques - Newser
Real time alert setup for Oculis Holding AG performanceRisk Management & Weekly High Conviction Ideas - Newser
How to recover losses in Oculis Holding AG Equity Warrant stockMarket Performance Summary & AI Powered Market Trend Analysis - Newser
Combining price and volume data for Oculis Holding AGMarket Activity Report & Low Risk Profit Maximizing Plans - Newser
How to build a dashboard for Oculis Holding AG stockTrade Signal Summary & Daily Chart Pattern Signal Reports - Newser
Should you wait for a breakout in Oculis Holding AGEarnings Overview Summary & Safe Entry Point Identification - Newser
Using flow based indicators on Oculis Holding AGEarnings Recap Summary & AI Driven Stock Movement Reports - Newser
Can trapped investors hope for a rebound in Oculis Holding AGTrade Entry Report & AI Enhanced Trading Alerts - Newser
how oculis holding ag equity warrant stock performs during market volatility2025 Top Gainers & Smart Swing Trading Techniques - Newser
What MACD signals say about Oculis Holding AGPortfolio Performance Summary & Real-Time Volume Spike Alerts - Newser
What makes Oculis Holding AG stock price move sharplyEntry Point & Daily Oversold Bounce Ideas - Newser
Can Oculis Holding AG Equity Warrant rally from current levels2025 Valuation Update & High Yield Stock Recommendations - Newser
Oculis Holding AG Equity Warrant stock volume spike explainedPortfolio Return Summary & AI Driven Stock Reports - Newser
What indicators show strength in Oculis Holding AG Equity WarrantTake Profit & Weekly Breakout Watchlists - Newser
Will Oculis Holding AG continue its uptrendWeekly Loss Report & High Conviction Trade Alerts - Newser
Can technical indicators confirm Oculis Holding AG Equity Warrant’s reversalQuarterly Performance Summary & Daily Volume Surge Signals - Newser
Will Oculis Holding AG outperform the marketQuarterly Risk Review & Real-Time Buy Zone Alerts - Newser
Multi asset correlation models including Oculis Holding AG Equity WarrantPortfolio Risk Report & Free Long-Term Investment Growth Plans - Newser
Signal strength of Oculis Holding AG Equity Warrant stock in tech scannersJuly 2025 Reactions & Consistent Income Trade Recommendations - Newser
Custom watchlist performance reports with Oculis Holding AG Equity WarrantWeekly Market Summary & Momentum Based Trading Ideas - Newser
Tools to assess Oculis Holding AG’s risk profileRate Hike & Community Verified Trade Signals - Newser
Heatmap analysis for Oculis Holding AG Equity Warrant and competitors2025 Market Outlook & Community Verified Trade Alerts - Newser
Will Oculis Holding AG Equity Warrant rebound enough to break evenJuly 2025 Snapshot & Daily Profit Maximizing Tips - Newser
Using economic indicators to assess Oculis Holding AG Equity Warrant potentialMarket Trend Report & High Return Trade Guides - Newser
Oculis Holding Ag Stock (OCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):